PERSPECTIVE THERAPEUTICS INCORPORATED (CATX)

Perspective Therapeutics had a ... -1.1 earnings per share for the current fiscal year. Several brokerages have commented on CATX. Wedbush restated an “outperform” rating and issued a $11.00 price target on shares of Perspective Therapeutics in a research note on Tuesday, May 5th. BTIG Research reis…

CAT heads into Q2 earnings with expectations for double-digit revenue and profit growth, but will tariffs and its premium valuation shape investors' next move?

Caterpillar's quarterly earnings exceeded consensus expectations across key industrial segments.Strong North American infrastructure demand and mining activity bolster revenue growth.Technical indicators suggest the stock is currently in an oversold condition.

Caterpillar looks like a risky pre-earnings play, but the recent dip could prove inviting for long-term investors.

InvestingPro’s Fair Value model ... the stock, even after the sell-off, may still have ~22% downside from current levels · A Gallup poll showing 70%+ of Americans oppose data center construction near their communities is a genuine structural headwind to CAT’s fastest-growing segment · The daily RSI …